References
1. Son CH, Kim YH, Lim S. A Study on Korean Oriental Medical Doctors’ Use of Uninsured Herbal Extracts and How to Promote the Insurance Coverage of Such Herbal Extracts. J Korean Oriental Med 2009;30(4):64–78.
2. Burns A1, Iliffe S. Dementia. BMJ 2009;338:b75.
3. Akhondzadeh S, Abbasi SH. Herbal medicine in the treatment of Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2006;21(2):113–8.
4. Cho HY, Hong SS, Whang WW, Cho SH. A Retrospective Study on Dementia Outpatients in Oriental Neuropsychiatry Clinic of One Medical Center. J of Oriental Neuropsychiatry 2010;21( 4):137–49.
5. Kim BG, Hyun KC, Kim JW, Whang WW. A Clinical Study on the Effects of Oriental Medical Treatment on Dementia of Alzheimer type. J of Oriental Neuropsychiatry 1998;9(1):25–43.
6. Terasawa K, Shimada Y, Kita T, Yamamoto T, Tosa H, Tanaka N, et al. Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine 1997;4( 1):15–22.
7. Matsuda Y, Kishi T, Shibayama H, Iwata N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol 2013;28(1):80–6.
8. Lim HS, Kim Y, Kim OS, Jeong SJ. Screening of 50 Korean Herbal formulas with Inhibitory Effects on Acetylcholinesterase Activity and Amyloid-β Aggregation. Kor J Pharmacogn 2016;47(3):287–294.
9. Ministry of Health and Welfare Notice. No. 2014-56. 2014. Apr. 18.
10. Lim HS, Ha H, Seo CS, Jin SE, Kim Y, Jeon WY, et al. Comparative study on efficacies and ingredient contents of different solvent extracts of Insampaedok-san. Kor J Herbology 2012;27( 6):115–122.
11. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
12. Habtemariam S. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer’s disease therapy. Nat Prod Commun 2011;6(8):1089–90.
13. Hellstrand E, Boland B, Walsh DM, Linse S. Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci 2010;1:13–8.
14. Lemkul JA, Bevan DR. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce “off-pathway” structures. Biochemistry 2012;51(30):5990–6009.
15. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med 1999;26:1231–7.
16. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016;8(1):23.
17. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008;148(5):379–97.
18. Naik RS, Hartmann J, Kiewert C, Duysen EG, Lockridge O, Klein J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J Pharm Pharm Sci 2009;12:79–85.
19. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915–7922.
20. Koo JS, Seo BI, Park JH, Roh SS. Analysis of papers on Oriental herbal medicines(prescriptions and herbs) for dementia. Kor J Herbology 2010;25:131–137.
21. Kim W, Jeon W, Heo E, Park S, Han C. Literature review and suggestions: dementia clinical studies in Korean Oriental Medicine. Kor J Orient Med 2011;17:39–46.
22. Vetrivel KS, Thinakaran G. Amyloidogenic processing of betaamyloid precursor protein in intracellular compartments. Neurology 2006;66:S69–73.
23. Eikelenboom P, van Gool WA. Neuroinflammatory perspectives on the two faces of Alzheimer’s disease. J Neural Transm 2004;111:281–94.
24. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1–7.
25. Ministry of Health and Welfare Notice. No. 2015-35. 2015. Feb. 23.
26. Hsu YL, Kuo PI, Tzeng TF, Sung SC, Yen MH, Lin YT, et al. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J Gastroenterol Hepatol 2008;23:e290–9.
27. Lu J, Wang JS, Kong LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol 2011;134:911–8.
28. Sasaki K, Sudo T, Kurusu T, Kiuchi T, Yoshizaki F. The mechanism of alteration of monoamine metabolism in brain regions in marble burying behavior-isolated housing mice and effect of oren-gedoku-to on this alteration. Yakugaku Zasshi 2000;120(6):559–67.
29. Chung SY, Kim JW, Lee JR, Jang HH, Kim HT, Whang WW. The Effects of Whangryonghaedoktang on Morris Water Maze and Tyrosine Hydroxylase Expression in Ventral Tegmental Area and Locus Coeruleus of the Chronic Mild Stress Animal Model of Depression. J of Oriental Neuropsychiatry 2003;14(1):1–16.
30. Guoxin DU, Shangqin LIU, Xiaoxi XIE, Li HE, Xiaoling ZHU, Wenyu RONG, et al. The efficacy of Huang-Lian-Jie-Du-Tang combined with chemotherapy for multiple myeloma. J Clinical Hematology 2012;25(5):306–8.
31. Sao L, Goto K, Shimada Y, Terasawa Y. Clinical comparative study of Huangyang detoxification hot water boiled rhubarb and atorvastatin for hyperlipidemia: including diet control, comparison with Placebo. Japan Toyo Kagaku Journal 2004;55:236.
32. Tohru S. Significance of Combined Use of Huangyaku Toxin for Insomnia in Manic Condition. Journal of Japan Toyo Medical Journal 2004;55:179.
33. Kim HY, Shin SH, Lee I. Neuroprotective Effect of Hwangryunhaedok-tang Against Glucose-deprivation Induced Cytotoxicity in PC-12 Cells. Korean J Oriental Physiology & Pathology 2008;22(6):1462–9.
34. Qing F, Xiaoping Z, Jianwei M, Mei S. The therapeutic effect of Huanglian Jiedu Decoction on AD rats and its effect on cytokine content. J of Tradit Chin Med 2004;29(6):575–8.
35. Qiu Y, Chen G, Mei G, Wang W, Wang K, Pan S. Effect of Huanglian Jiedu Decoction on free radical metabolism and IL-6, IL-1β content in brain tissue of mice with APP/PS1 double transgenic Alzheimer’s disease. Stroke and neurological diseases 2011;18(2):72–4.
36. Chen G, Shan P, Qiu Y. Clinical study of Huanglian Jiedu Decoction in the treatment of senile dementia (Heart and Liver). Chinese Journal of Emergency Medicine 2007;16(4):386–7.
37. Ministry of Health and Welfare Notice. No. 2017-214. 2017. Nov. 27.
38. Lee JY, Kook YB. Effects of Samhwangsasim-tang on obesity-related metabolic disease in mice. Herbal formula science 2014;22(1):93–104.
39. Lee HC, Jeong MY, Choi JH, Park SY. Effects of Samhwangsasim-tang Gamibang on Atopic Dermatitis in Mice. Herbal formula science 2017;25(3):337–47.
40. Koo JS, Kwon DK, Seo BI, Park JH, Roh SS, Kim SM, et al. The Antimicrobial Activity of Samhwangsasimtang against pseudomonas aeruginosa 38 isolated from an acne patient. Kor J Herbology 2010;25(2):11–9.
41. Seok SH, Kim JH, Kim GW, Koo BS. A case of insomnia incurable by neuropsychiatric medication alone, but made possible with Sam-Hwang-Sa-Sim-Tang. J of Oriental Neuropsychiatry 2006;17(3):117–29.
42. Shin SU, Lee JS, Kim SS. Effect of modified Samhwangsasim-tang(三黃瀉心湯加味方) on Suspicious Dementia of Multiple Infarction Induced by Hypoxia: A Case Report. J Oriental Rehab Med 2001;11(2):219–26.